Table of Contents
Hepatitis Research and Treatment
Volume 2013 (2013), Article ID 757246, 7 pages
http://dx.doi.org/10.1155/2013/757246
Clinical Study

Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection

1Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
2Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
3Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
4Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
5Department of Pediatrics, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

Received 29 May 2013; Revised 3 September 2013; Accepted 20 September 2013

Academic Editor: Piero Luigi Almasio

Copyright © 2013 Kittiyod Poovorawan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Ganem and A. M. Prince, “Hepatitis B virus infection—natural history and clinical consequences,” The New England Journal of Medicine, vol. 350, no. 11, pp. 1118–1129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Poovorawan, V. Chongsrisawat, A. Theamboonlers, H. L. Bock, M. Leyssen, and J.-M. Jacquet, “Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand,” Vaccine, vol. 28, no. 3, pp. 730–736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Chimparlee, S. Oota, S. Phikulsod, P. Tangkijvanich, and Y. Poovorawan, “Hepatitis B and hepatitis C Virus in Thai blood donors,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 42, no. 3, pp. 609–615, 2011. View at Google Scholar · View at Scopus
  4. R. S. Tedder, S. Ijaz, N. Gilbert et al., “Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers,” Journal of Medical Virology, vol. 68, no. 4, pp. 505–512, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. F. Lok and B. J. McMahon, “Chronic hepatitis B: update 2009,” Hepatology, vol. 50, no. 3, pp. 661–662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-Y. Zhang, Z. Zhang, F. Lin et al., “Interleukin-17-producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B,” Hepatology, vol. 51, no. 1, pp. 81–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-F. Wu, T.-C. Wu, C.-H. Chen et al., “Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion,” Gastroenterology, vol. 138, no. 1, pp. 165–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Shimizu, “T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection,” The World Journal of Gastroenterology, vol. 18, no. 20, pp. 2443–2451, 2012. View at Publisher · View at Google Scholar
  9. D. C. Rockey, S. H. Caldwell, Z. D. Goodman, R. C. Nelson, and A. D. Smith, “Liver biopsy,” Hepatology, vol. 49, no. 3, pp. 1017–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. G. Knodell, K. G. Ishak, W. C. Black et al., “Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis,” Hepatology, vol. 1, no. 5, pp. 431–435, 1981. View at Google Scholar · View at Scopus
  11. J.-T. Tang, J.-Y. Fang, W.-Q. Gu, and E.-L. Li, “T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics,” The World Journal of Gastroenterology, vol. 12, no. 19, pp. 3015–3019, 2006. View at Google Scholar · View at Scopus
  12. P. Kennedy, E. Sandalova, J. Jo et al., “Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B,” Gastroenterology, vol. 143, no. 3, pp. 637–645, 2012. View at Publisher · View at Google Scholar
  13. A. Bertoletti, M. M. D'Elios, C. Boni et al., “Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections,” Gastroenterology, vol. 112, no. 1, pp. 193–199, 1997. View at Google Scholar · View at Scopus
  14. J. Wang, Y. Cai, H. Ji et al., “Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B,” Journal of Interferon & Cytokine Research, vol. 32, no. 6, pp. 248–253, 2012. View at Google Scholar
  15. S. Khan, A. Bhargava, N. Pathak, K. K. Maudar, S. Varshney, and P. K. Mishra, “Circulating biomarkers and their possible role in pathogenesis of chronic hepatitis B and C viral infections,” Indian Journal of Clinical Biochemistry, vol. 26, no. 2, pp. 161–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Bozkaya, M. Bozdayi, R. Turkyilmaz et al., “Circulating IL-2, IL-10 and TNF-α in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease,” Hepato-Gastroenterology, vol. 47, no. 36, pp. 1675–1679, 2000. View at Google Scholar · View at Scopus
  17. A. Penna, G. del Prete, A. Cavalli et al., “Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B,” Hepatology, vol. 25, no. 4, pp. 1022–1027, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Szkaradkiewicz, A. Jopek, and J. Wysocki, “Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection,” Antiviral Research, vol. 66, no. 1, pp. 23–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. I. Rigopoulou, D. Suri, S. Chokshi et al., “Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity,” Hepatology, vol. 42, no. 5, pp. 1028–1036, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ejrnaes, C. M. Filippi, M. M. Martinic et al., “Resolution of a chronic viral infection after interleukin-10 receptor blockade,” Journal of Experimental Medicine, vol. 203, no. 11, pp. 2461–2472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Shi and S.-H. Guan, “Increased apoptosis in HepG2.2.15 cells with hepatitis B virus expression by synergistic induction of interferon-γ and tumour necrosis factor-α,” Liver International, vol. 29, no. 3, pp. 349–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Puro and R. J. Schneider, “Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA,” Journal of Virology, vol. 81, no. 14, pp. 7351–7362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Reifenberg, E. Hildt, B. Lecher et al., “IFNγ expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers,” Liver International, vol. 26, no. 8, pp. 986–993, 2006. View at Publisher · View at Google Scholar · View at Scopus